Question · asked by 1 review
Dihydropyridine calcium channel blockers vs placebo: Variation in the decrease in 24‐hour ambulatory hourly SBP (at 3 to 12 weeks)
- Population
- adults with primary hypertension
- Intervention
- Dihydropyridine calcium channel blockers
- Comparison
- placebo
- Outcome
- Variation in the decrease in 24‐hour ambulatory hourly SBP (at 3 to 12 weeks)
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Dihydropyridine calcium channel blockers vs placebo Variation in the decrease in 24‐hour ambulatory hourly systolic blood pressure at 3‐12 weeks · adults with primary hypertension Time course for blood pressure lowering of dihydropyridine calcium channel blockers (2014) · Cochrane Headline outcomes only | no estimate extracted | 16 studies · 2768 participants | Moderate |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Time course for blood pressure lowering of dihydropyridine calcium channel blockers 2014 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.